Reveals decreased biomarkers in polycystic ovary syndrome, suggesting diagnostic potential for metabolic disturbances.
Serum levels of EPDR1 and NRG4 were significantly decreased in PCOS patients and showed significant correlations with key metabolic and endocrine parameters (BMI, T, HOMA-IR, LH/FSH ratio, and lipid profiles). These findings highlight their potential value as diagnostic biomarkers for PCOS, reflecting the associated metabolic disturbances.
No takes yet. Share an insight, caveat, or question.
Xiaopang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: